Thursday, February 16, 2012

Roche Says Counterfeit Cancer Drug Avastin Being Investigated by FDA

Roche Says Counterfeit Cancer Drug Avastin Being Investigated by U.S. FDA - Bloomberg:

"Roche and the Food and Drug Administration are seeking to prevent the fake cancer drug, which doesn’t include the active ingredient bevacizumab, from being distributed further, the company’s Genentech unit said in an e-mail late yesterday. The FDA notified the company about the issue in December, said Edward Lang, a spokesman for Roche’s South San Francisco, California-based unit.

“We’re working with the FDA, as well as with law enforcement authorities to aid in their investigation,” Lang said today in an interview. “We’ve analyzed some of the vials, we found no therapeutic protein there. So there’s no Avastin, there’s no generic form of Avastin.”"

'via Blog this'

Return Home: The Health, Drug, Prescription, and GMP Supersite Blog

GMP Posters by SkillsPlus Intl Inc.
SkillsPlus Intl Inc. - GMP and QSR Compliance Training Experts
SkillsPlus Intl Info Blog
The Health, Drug, Prescription, and GMP Supersite Gift Store 

Enhanced by Zemanta

No comments:

From SkillsPlus International Inc.

Custom Search

Even More Resources, Books, & Things (many from Amazon.com)

FDA, GMPs, QSR, GCP, GLP, GXP:
    GMP Training Gifts & Giveaways